Blue Trail Partners — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Ataraxis AIataraxis.ai in 𝕏Dec 2024

Ataraxis develops AI foundation models that analyze multi-modal patient data, including pathology slide images, to assess cancer aggressiveness and predict recurrence risk and treatment response.

AI & Machine LearningBiotechHealthtechNew York, US

Krzysztof Geras(Founder)inJan Witowski(Founder)in

BoardKrish Ramadural(Director)Rohan Ganeshananthan(Director)

Co-investorsAIX Ventures Floating Point Giant Ventures Global Llp Obvious Ventures Transpose Platform Management Bertelsmann Investments +1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.